Molecular Partners (Switzerland) Performance

Molecular Partners Relative Risk vs. Return Landscape

If you would invest  310.00  in Molecular Partners AG on November 11, 2025 and sell it today you would earn a total of  50.00  from holding Molecular Partners AG or generate 16.13% return on investment over 90 days. Molecular Partners AG is generating 0.3102% of daily returns and assumes 3.4327% volatility on return distribution over the 90 days horizon. Simply put, 30% of stocks are less volatile than Molecular, and 94% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days.Assuming the 90 days trading horizon Molecular Partners is expected to generate 4.25 times more return on investment than the market. However, the company is 4.25 times more volatile than its market benchmark. It trades about 0.09 of its potential returns per unit of risk. The Dow Jones Industrial is currently generating roughly 0.09 per unit of risk.

Molecular Partners Target Price Odds to finish over Current Price

Assuming the 90 days trading horizon Molecular Partners has a beta of 0.42. This indicates as returns on the market go up, Molecular Partners average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding Molecular Partners AG will be expected to be much smaller as well. Additionally Molecular Partners AG has an alpha of 0.3002, implying that it can generate a 0.3 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta).

Predictive Modules for Molecular Partners

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Molecular Partners. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.

Hype Prediction Low Estimated High 0.13 3.56 6.99 Details

Intrinsic Valuation Low Real High 0.15 2.90 6.33 Details

Earnings Estimates (0) Low Projected EPS High -0.35 -0.31 -0.35 Details

Molecular Partners Risk Indicators

For the most part, the last 10-20 years have been a very volatile time for the stock market. Molecular Partners is not an exception. The market had few large corrections towards the Molecular Partners' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Molecular Partners AG, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Molecular Partners within the framework of very fundamental risk indicators.

Molecular Partners Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Molecular Partners for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Molecular Partners can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.

Molecular Partners Price Density Drivers

Molecular Partners Fundamentals Growth

When running Molecular Partners' price analysis, check to measure Molecular Partners' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Molecular Partners is operating at the current time. Most of Molecular Partners' value examination focuses on studying past and present price action to predict the probability of Molecular Partners' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Molecular Partners' price. Additionally, you may evaluate how the addition of Molecular Partners to your portfolios can decrease your overall portfolio volatility.